Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTABLETGeneric

AXITINIB

AXITINIB

Standard Dose
1MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary

Approval overview AXITINIB is listed in Drugs@FDA under application 219705 (ANDA).

Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient AXITINIB Form and strength TABLET - 1MG Sponsor SANDOZ INC Submission history Latest submission status date: 2025-10-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview AXITINIB is listed in Drugs@FDA under application 219705 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient AXITINIB Form and strength TABLET - 1MG Sponsor SANDOZ INC Submission history Latest submission status date: 2025-10-07 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.